| 1 |
Noninvasive evaluation of aortic regurgitation by continuous-wave Doppler echocardiography.
T Masuyama, Kenji Kodama, Akira Kitabatake et al. · Circulation
Open access |
Mar 1986 |
116 |
| 2 |
A two-term model of the confinement in Elmy H-modes using the global confinement and pedestal databases
J.G. Cordey, for the ITPA H-Mode Database Workin Group, the ITPA Pedestal Database Working Group · Nuclear Fusion
Open access |
17 Jul 2003 |
87 |
| 3 |
Alpha 1-adrenoceptor activity regulates release of adenosine from the ischemic myocardium in dogs.
Masafumi Kitakaze, M Hori, Jun Tamai et al. · Circulation Research
Open access |
May 1987 |
85 |
| 4 |
Packaging zinc, fibrinogen, and factor XIII in platelet α‐granules
Gerard S. Marx, Gil Korner, Xiaode Mou et al. · Journal of Cellular Physiology
|
Sep 1993 |
77 |
| 5 |
Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPD
Jan N Stolk, Naveh Tov, Kenneth R. Chapman et al. · European Respiratory Journal
Open access |
29 Aug 2019 |
69 |
| 6 |
Hemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction.
Hideyuki Sato, Michitoshi Inoue, Taizo MATSUYAMA et al. · Circulation
Open access |
1987 |
57 |
| 7 |
The effect of the calcium antagonist nimodipine on the gerbil model of experimental cerebral ischemia.
Akio Fujisawa, Masayasu Matsumoto, T. Matsuyama et al. · Stroke
Open access |
Jul 1986 |
47 |
| 8 |
Studies of advanced glycation end products and oxidation biomarkers for type 2 diabetes
Chung‐Jung Chiu, Naila Rabbani, Sheldon Rowan et al. · BioFactors
Open access |
May 2018 |
39 |
| 9 |
Left ventricular aneurysm and the prediction of left ventricular enlargement studied by two-dimensional echocardiography: quantitative assessment of aneurysm size in relation to clinical course.
M Matsumoto, Fumio Watanabe, Akihiko Goto et al. · Circulation
Open access |
Aug 1985 |
39 |
| 10 |
Therapeutic Application of Alpha-1 Antitrypsin in COVID-19
Felix Ritzmann, Praneeth Chitirala, Nadine Krüger et al. · American Journal of Respiratory and Critical Care Medicine
Open access |
7 May 2021 |
36 |
| 11 |
Mechanistic Evidence in Support of Alpha1-Antitrypsin as a Therapeutic Approach for Type 1 Diabetes
Gabriella Fleixo-Lima, H. Costa Ventura, Michal Medini et al. · Journal of Diabetes Science and Technology
Open access |
25 Aug 2014 |
35 |
| 12 |
Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus
Marianna Rachmiel, Pnina Strauss, Nitzan Dror et al. · Pediatric Diabetes
|
15 Jun 2015 |
35 |
| 13 |
Distinct anti-inflammatory properties of alpha1-antitrypsin and corticosteroids reveal unique underlying mechanisms of action
Ronen Schuster, Noa Motola-Kalay, Boris M. Baranovski et al. · Cellular Immunology
|
24 Jul 2020 |
32 |
| 14 |
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia®) in the Treatment of Recent-Onset Type 1 Diabetes
Yael Lebenthal, Avivit Brener, Eli Hershkovitz et al. · International Journal of Molecular Sciences
Open access |
29 Nov 2019 |
23 |
| 15 |
Biochemical Efficacy and Safety of a New, Ready-to-Use, Liquid Alpha-1-Proteinase Inhibitor, GLASSIA (Alpha 1 -Proteinase Inhibitor (Human), Intravenous)
Robert A. Sandhaus, James M. Stocks, Farshid N. Rouhani et al. · COPD Journal of Chronic Obstructive Pulmonary Disease
Open access |
3 Jul 2013 |
20 |
| 16 |
Safety and efficacy of rabies immunoglobulin in pediatric patients with suspected exposure
Nicholas Hobart-Porter, Michal Stein, Naveh Toh et al. · Human Vaccines & Immunotherapeutics
Open access |
9 Feb 2021 |
18 |
| 17 |
Effect of aspirin and ticlopidine on platelet deposition in carotid atherosclerosis: assessment by indium-111 platelet scintigraphy.
Y Isaka, Kazufumi Kimura, Hideki Etani et al. · Stroke
|
Nov 1986 |
16 |
| 18 |
A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019
Yasmin Maor, Eilat Shinar, Marina Izak et al. · Clinical Infectious Diseases
Open access |
23 May 2023 |
14 |
| 19 |
Exploration of α1-Antitrypsin Treatment Protocol for Islet Transplantation: Dosing Plan and Route of Administration
Boris M. Baranovski, Eyal Ozeri, Galit Shahaf et al. · Journal of Pharmacology and Experimental Therapeutics
Open access |
8 Nov 2016 |
14 |
| 20 |
Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial
Mark Matson, Eran Schenker, Michal Stein et al. · Human Vaccines & Immunotherapeutics
Open access |
24 Sep 2019 |
13 |
| 21 |
Inhaled alpha-1 antitrypsin (AAT) restores lower respiratory tract protease–antiprotease homoeostasis and reduces inflammation in AAT-deficient individuals: a randomised phase 2 study
Mark Brantly, James M. Stocks, Jorge E. Lascano et al. · ERJ Open Research
Open access |
22 Aug 2024 |
12 |
| 22 |
A new approach to antithrombotic therapy--evaluation of combined therapy of thromboxane synthetase inhibitor and very low dose of aspirin.
Kazuyuki Nagatsuka, Osamu Uyama, Saiji Nakabayashi et al. · Stroke
Open access |
Sep 1985 |
6 |
| 23 |
Governmental Non-Pharmaceutical Interventions during the COVID-19 Pandemic and the COPD Exacerbation and Respiratory Infection Rate in Patients with Alpha-1 Antitrypsin Deficiency
Naomi Kappe, Noga Alagem, Naveh Tov et al. · COPD Journal of Chronic Obstructive Pulmonary Disease
Open access |
4 Sep 2023 |
1 |
| 24 |
Intravenous Alpha-1 Antitrypsin Therapy for Critically Ill COVID-19 Patients.
Ori Wand, David Ben Dahan, Naveh Tov et al. · PubMed
|
Jul 2022 |
1 |
| 25 |
15. Waldemar Jochelson, Franz Boas et la Sibérie
Isabelle Kalinowski
Book chapterOpen access |
2018 |
1 |
| 26 |
Specific, High-Avidity Transient Receptor Potential Ion Channel Inhibitors Demonstrate an Approach to Keratoderma Therapy
Ephraim Brener, T. Mashriki, Ezra Ella et al. · Journal of Investigative Dermatology
|
27 May 2025 |
0 |
| 27 |
Differences in measles antibody titers among IVIGs and hyperimmune globulins
Camille N. Kotton, Yonit Tiberman, Tamar Auerbach et al. · Transfusion
Open access |
30 Apr 2025 |
0 |
| 28 |
Comparative Functional Properties of CMV Immune Globulin vs Polyvalent IGIV Against CMV and Other Viruses
Tamar Auerbach, Yonit Tiberman, Diane Krieger et al. · The Journal of Heart and Lung Transplantation
Open access |
Apr 2025 |
0 |
| 29 |
A Phase II, Prospective, Open Label, Standard of Care (SOC) Controlled, Study to Evaluate the Safety and Efficacy of Glassia® in Lung Transplantation during the First 6 Months
M.R. Kramer, Yonit Rosen-Krauss, Dror Rosengarten et al. · The Journal of Heart and Lung Transplantation
|
15 Mar 2019 |
0 |
| 30 |
Translation of Patients' Spoken Words to Medical Terms
Sigekuni Tachibana · Spinal Surgery
Open access |
2014 |
0 |
| 31 |
Description of Tabanus inaensis n. sp. from Nagano Prefecture, Japan
Fumiyoshi ASAKAWA, Hirosi Takahasi · Medical Entomology and Zoology
Open access |
1975 |
0 |
| 32 |
Endoscopic Treatment of Emphysema
Anupam Kumar, James K. Stoller, Michael S. Machuzak · Clinical Pulmonary Medicine
|
23 Jun 2016 |
0 |
| 33 |
Evaluation of sonographic findings of superficial lymph nodes in the diagnosis of non-Hodgkin lymphoma recurrence by multivariate logistic regression analysis
Fumi Yoshioka, Sachiko Tanaka, Tsugio Kitamura et al. · Choonpa Igaku
|
2011 |
0 |
| 34 |
Kampo Therapy on Xerostomia in 4 cases of Sjoegren Syndrome.
K. Matsusita, Akiyoshi Konno, Keiichirou KAMADA · 日本東洋醫學雜誌
Open access |
1993 |
0 |